American Vanguard (AVD)
Market Price (2/4/2026): $5.125 | Market Cap: $146.1 MilSector: Materials | Industry: Fertilizers & Agricultural Chemicals
American Vanguard (AVD)
Market Price (2/4/2026): $5.125Market Cap: $146.1 MilSector: MaterialsIndustry: Fertilizers & Agricultural Chemicals
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Megatrend and thematic driversMegatrends include Food Security & Sustainable Agriculture, Advanced Materials, and Sustainable Resource Management. Themes include Crop Protection & Enhancement, Show more. | Weak multi-year price returns2Y Excs Rtn is -93%, 3Y Excs Rtn is -147% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -13 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -2.5% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 126% | ||
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -4.3%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -4.5% | ||
| Not cash flow generativeFCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.0% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -81% | ||
| Key risksAVD key risks include [1] significant financial instability and operational control deficiencies, Show more. |
| Megatrend and thematic driversMegatrends include Food Security & Sustainable Agriculture, Advanced Materials, and Sustainable Resource Management. Themes include Crop Protection & Enhancement, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -93%, 3Y Excs Rtn is -147% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -13 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -2.5% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 126% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -4.3%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -4.5% |
| Not cash flow generativeFCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.0% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -81% |
| Key risksAVD key risks include [1] significant financial instability and operational control deficiencies, Show more. |
Qualitative Assessment
AI Analysis | Feedback
American Vanguard (AVD) stock has gained about 15% since 10/31/2025 because of the following key factors:
1. American Vanguard's strong operational improvements in its Q3 2025 earnings report, despite an EPS miss, contributed to the stock's gain. The company reported a significant 350% year-over-year surge in adjusted EBITDA and a dramatic improvement in gross profit margin from 15% to 29%. Furthermore, operating costs were reduced by 11% in Q3 and 14% year-to-date, demonstrating enhanced cost efficiencies. This indicated a strengthened business even if the stock initially fell on the earnings release.
2. Optimistic outlook and reiterated guidance for 2026 from management played a key role. CEO Dak Kaye expressed confidence for 2026, anticipating a return to normalized buying patterns in Q4 2025 and Q1 2026, alongside expected volume increases. The company also maintained its full-year 2025 adjusted EBITDA target of $40-$44 million and hinted at potential portfolio expansion through acquisitions.
Show more
1. American Vanguard's strong operational improvements in its Q3 2025 earnings report, despite an EPS miss, contributed to the stock's gain. The company reported a significant 350% year-over-year surge in adjusted EBITDA and a dramatic improvement in gross profit margin from 15% to 29%. Furthermore, operating costs were reduced by 11% in Q3 and 14% year-to-date, demonstrating enhanced cost efficiencies. This indicated a strengthened business even if the stock initially fell on the earnings release.
2. Optimistic outlook and reiterated guidance for 2026 from management played a key role. CEO Dak Kaye expressed confidence for 2026, anticipating a return to normalized buying patterns in Q4 2025 and Q1 2026, alongside expected volume increases. The company also maintained its full-year 2025 adjusted EBITDA target of $40-$44 million and hinted at potential portfolio expansion through acquisitions.
Show more
Stock Movement Drivers
Fundamental Drivers
The 14.5% change in AVD stock from 10/31/2025 to 2/3/2026 was primarily driven by a 15.0% change in the company's P/S Multiple.| (LTM values as of) | 10312025 | 2032026 | Change |
|---|---|---|---|
| Stock Price ($) | 4.47 | 5.12 | 14.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 529 | 530 | 0.2% |
| P/S Multiple | 0.2 | 0.3 | 15.0% |
| Shares Outstanding (Mil) | 28 | 29 | -0.6% |
| Cumulative Contribution | 14.5% |
Market Drivers
10/31/2025 to 2/3/2026| Return | Correlation | |
|---|---|---|
| AVD | 14.5% | |
| Market (SPY) | 1.1% | 19.5% |
| Sector (XLB) | 18.4% | 36.6% |
Fundamental Drivers
The 32.6% change in AVD stock from 7/31/2025 to 2/3/2026 was primarily driven by a 33.2% change in the company's P/S Multiple.| (LTM values as of) | 7312025 | 2032026 | Change |
|---|---|---|---|
| Stock Price ($) | 3.86 | 5.12 | 32.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 529 | 530 | 0.2% |
| P/S Multiple | 0.2 | 0.3 | 33.2% |
| Shares Outstanding (Mil) | 28 | 29 | -0.6% |
| Cumulative Contribution | 32.6% |
Market Drivers
7/31/2025 to 2/3/2026| Return | Correlation | |
|---|---|---|
| AVD | 32.6% | |
| Market (SPY) | 9.4% | 15.2% |
| Sector (XLB) | 16.1% | 40.7% |
Fundamental Drivers
The -17.2% change in AVD stock from 1/31/2025 to 2/3/2026 was primarily driven by a -12.4% change in the company's P/S Multiple.| (LTM values as of) | 1312025 | 2032026 | Change |
|---|---|---|---|
| Stock Price ($) | 6.18 | 5.12 | -17.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 554 | 530 | -4.3% |
| P/S Multiple | 0.3 | 0.3 | -12.4% |
| Shares Outstanding (Mil) | 28 | 29 | -1.2% |
| Cumulative Contribution | -17.2% |
Market Drivers
1/31/2025 to 2/3/2026| Return | Correlation | |
|---|---|---|
| AVD | -17.2% | |
| Market (SPY) | 15.6% | 26.9% |
| Sector (XLB) | 15.9% | 40.2% |
Fundamental Drivers
The -77.0% change in AVD stock from 1/31/2023 to 2/3/2026 was primarily driven by a -74.2% change in the company's P/S Multiple.| (LTM values as of) | 1312023 | 2032026 | Change |
|---|---|---|---|
| Stock Price ($) | 22.27 | 5.12 | -77.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 610 | 530 | -13.1% |
| P/S Multiple | 1.1 | 0.3 | -74.2% |
| Shares Outstanding (Mil) | 29 | 29 | 2.5% |
| Cumulative Contribution | -77.0% |
Market Drivers
1/31/2023 to 2/3/2026| Return | Correlation | |
|---|---|---|
| AVD | -77.0% | |
| Market (SPY) | 75.9% | 21.1% |
| Sector (XLB) | 26.4% | 32.5% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| AVD Return | 6% | 33% | -49% | -58% | -17% | 33% | -66% |
| Peers Return | 48% | 15% | -21% | -7% | -3% | 13% | 37% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 2% | 86% |
Monthly Win Rates [3] | |||||||
| AVD Win Rate | 42% | 42% | 50% | 25% | 42% | 50% | |
| Peers Win Rate | 65% | 58% | 42% | 48% | 50% | 60% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 100% | |
Max Drawdowns [4] | |||||||
| AVD Max Drawdown | -8% | -13% | -61% | -60% | -27% | -2% | |
| Peers Max Drawdown | -5% | -6% | -33% | -18% | -20% | -1% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: CTVA, FMC, NTR, MOS, CF.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/3/2026 (YTD)
How Low Can It Go
| Event | AVD | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -67.4% | -25.4% |
| % Gain to Breakeven | 207.0% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -40.6% | -33.9% |
| % Gain to Breakeven | 68.2% | 51.3% |
| Time to Breakeven | 336 days | 148 days |
| 2018 Correction | ||
| % Loss | -46.3% | -19.8% |
| % Gain to Breakeven | 86.3% | 24.7% |
| Time to Breakeven | 1,014 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -65.1% | -56.8% |
| % Gain to Breakeven | 186.4% | 131.3% |
| Time to Breakeven | 850 days | 1,480 days |
Compare to CTVA, FMC, NTR, MOS, CF
In The Past
American Vanguard's stock fell -67.4% during the 2022 Inflation Shock from a high on 6/2/2022. A -67.4% loss requires a 207.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About American Vanguard (AVD)
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.
AI Analysis | Feedback
1. Scotts Miracle-Gro for commercial farms, providing the pesticides, herbicides, and other crop protection products farmers need.
2. A specialized agricultural chemicals company, similar to a smaller Corteva or FMC.
AI Analysis | Feedback
- Insecticides: Chemical solutions designed to control insect pests that damage agricultural crops and other plants.
- Herbicides: Chemical products used to manage and control unwanted weeds in various agricultural and non-agricultural settings.
- Fungicides: Chemical agents employed to prevent and control fungal diseases affecting crops, turf, and ornamental plants.
- Soil Fumigants: Specialized chemicals applied to the soil to eliminate a broad range of pests, diseases, and weeds prior to planting.
- Nematicides: Chemical treatments specifically targeting and controlling plant-parasitic nematodes in agricultural soils.
- Turf & Ornamental Products: Solutions tailored for the management and health of non-crop areas such as golf courses, lawns, and nurseries.
- Public & Animal Health Products: Products aimed at protecting human and animal health by controlling pests and disease vectors in public and livestock environments.
- Precision Application Systems (e.g., SIMPAS): Advanced technological platforms enabling precise, variable-rate application of crop protection products directly into the soil.
- Biological Products: Environmentally friendly solutions derived from natural sources, used for pest control, disease management, and plant growth enhancement.
AI Analysis | Feedback
American Vanguard (AVD) primarily sells its agricultural and consumer products to other companies, making its business model predominantly Business-to-Business (B2B).
According to American Vanguard's 2023 Annual Report (10-K filing), the company sells its agricultural products principally to large distributors and cooperatives. These entities then resell the products to independent dealers, smaller regional distributors, and/or directly to growers. For its consumer products, AVD generally sells directly to major retailers or distributors of consumer products.
American Vanguard's financial filings indicate the presence of significant customers, but the company does not disclose the specific names of these major customers due to commercial confidentiality. However, it does provide the following information regarding their sales concentration:
- One major distributor (for both domestic and export sales) accounted for approximately 41% of American Vanguard's consolidated net sales for the year ended December 31, 2023.
- Another major distributor accounted for approximately 15% of American Vanguard's consolidated net sales for the year ended December 31, 2023.
While the specific names of these high-volume customers are not publicly disclosed by American Vanguard, they are generally large, established agricultural distributors or major retail chains for consumer products in the industry.
AI Analysis | Feedback
nullAI Analysis | Feedback
Douglas A. "Dak" Kaye III, Chief Executive Officer
Mr. Kaye joined American Vanguard in 2024 and became CEO in January 2025. Prior to this, he served in various senior leadership roles at Albaugh LLC, a global crop protection company, including President, North America, Group Chief Commercial Officer, and President of the European region for seven years. Before Albaugh, he was the CFO and a Director at a non-crop subsidiary of the crop protection company Adama, and Co-CEO at an international automotive logistics organization. He also previously worked at Arthur Andersen, LLP.
David T. Johnson, Vice President, Chief Financial Officer, Principal Accounting Officer and Treasurer
Mr. Johnson has served as CFO of American Vanguard since March 2008. Before joining American Vanguard, he was the Finance Director for Amcor Flexibles UK Ltd., a manufacturer of decorative packaging, from 2003 to 2008. He also served as Vice President of Finance for Sterer Engineering, a subsidiary of Eaton Aerospace, from 2001 to 2003. Mr. Johnson possesses over 20 years of financial management experience across multinational corporations and also serves as Treasurer at TyraTech, Inc.
Eric G. Wintemute, Chairman of the Board
Mr. Wintemute served as President and Chief Executive Officer of American Vanguard from July 1994 until June 2011, and then as Chairman and CEO from June 2011 until his retirement as CEO in late 2024, marking 30 years in the CEO role and 47 years with the company. He co-founded GemChem Inc. in 1991, which was acquired by American Vanguard Corp. in November 1993. He was also a member of the board of directors of TyraTech Inc. from 2013 to 2018.
Timothy J. Donnelly, Chief Administrative Officer, Chief Information Officer, General Counsel and Secretary
Mr. Donnelly has served as Chief Information Officer, General Counsel, and Secretary of American Vanguard since June 2010. He also took on responsibility for Human Resources and Risk Management in 2009. Prior to joining American Vanguard in October 2005, he was Vice President, General Counsel, and Secretary for DDi Corp. from September 2000 to October 2005. His earlier career included roles as Assistant General Counsel at Rockwell International Corporation and an Associate with Latham & Watkins.
Shirin Khosravi, Senior Vice President, Human Resources
Ms. Khosravi joined American Vanguard in October 2023 as Senior Vice President of Human Resources.
AI Analysis | Feedback
The key risks to American Vanguard's (AVD) business include:
- Financial Instability and Operational Control Deficiencies: American Vanguard has experienced significant financial challenges, marked by delayed filings of its 2024 Form 10-K and Q1 2025 Form 10-Q, leading to a notice of non-compliance from the NYSE. These delays were attributed to control deficiencies at its Australian unit and complications from an ERP system rollout. The company has seen sharp declines in revenue and gross margins, with gross margins falling from 31% to 26% in Q1 2025, and adjusted EBITDA plummeting. Furthermore, American Vanguard faces severe liquidity constraints, evident from a 34.49% year-over-year collapse in working capital, which has curtailed its ability to reinvest in R&D and capital expenditures. The company also carries a substantial debt burden, reporting approximately $189 million in debt at the end of Q1 2025 and $182.3 million at Q3 2025, incurring about $16 million in annual interest costs. This financial stress has resulted in slashed dividends and a defensive liquidity stance, with amended credit facility terms restricting cash dividends and introducing monthly liquidity and EBITDA thresholds.
- Market and Pricing Pressures: The company operates within a "brutal pricing environment" characterized as "cannibalistic," driven by distributors' thinning working capital and hyper-aggressive discounting by competitors. This has directly contributed to the erosion of American Vanguard's gross margins. The agricultural sector has also been experiencing a prolonged "destocking cycle," where customers reduce existing inventories instead of purchasing new products, placing extended pressure on sales and margins. This cyclical downturn in major crops has severely impacted the company's performance in 2023 and 2024.
- Regulatory Challenges and Product-Related Liabilities: American Vanguard's business relies heavily on approvals and periodic re-registrations from regulatory bodies like the U.S. Environmental Protection Agency (EPA) for its key chemical products. Any issues in this area could force product withdrawals or necessitate costly reformulations. A significant example of this risk materializing was the 2024 recall and discontinuance of the pesticide Dacthal due to regulatory cancellation in the US, which resulted in substantial one-time losses of approximately $36 million from inventory write-downs and recall costs. The company also faced a $7.0 million product liability charge in Q3 2025 related to an ornamental insecticide.
AI Analysis | Feedback
The clear emerging threat is the rapid growth and increasing adoption of biological crop protection products. These products, including biopesticides and biostimulants, offer alternative solutions for pest and disease management and plant health, often with better environmental profiles and less stringent regulatory hurdles compared to traditional synthetic chemical pesticides. As scientific advancements improve their efficacy and farmers face increasing pressure for sustainable practices and reduced chemical residues, the biologicals market is expanding rapidly, potentially displacing demand for conventional synthetic chemical products that constitute a significant portion of American Vanguard's portfolio.
AI Analysis | Feedback
American Vanguard Corporation (AVD) is a diversified specialty and agricultural products company. Its main product and service categories include crop protection chemicals (herbicides, insecticides, fungicides), soil fumigants, agricultural biologicals, and precision agriculture technologies. American Vanguard also operates in turf and ornamental management and commercial and consumer pest control, though specific market sizes for these niche areas were not explicitly identified in the provided information.
Addressable Market Sizes for American Vanguard's Main Products and Services:
-
Crop Protection Chemicals: The global crop protection chemicals market was valued at approximately USD 96.05 billion in 2024 and is projected to reach about USD 141.69 billion by 2033.
- Region: Global
- The North American crop protection chemicals market was evaluated at USD 22.32 billion in 2024 and is projected to reach around USD 40.08 billion by 2034.
-
Herbicides: The global herbicides market was valued at USD 41.51 billion in 2024 and is expected to reach USD 58.48 billion by 2029.
- Region: Global
-
Insecticides: The global insecticides market size was USD 23.63 billion in 2024 and is projected to grow to USD 37.03 billion in 2029.
- Region: Global
-
Fungicides: The global fungicides market size reached USD 20.5 billion in 2024 and is expected to reach USD 29.3 billion by 2033.
- Region: Global
-
Soil Fumigants: The global soil fumigant market size was USD 2.51 billion (USD 2514.5 million) in 2024 and is expected to expand to USD 3.42 billion (USD 3421.88 million) by 2031.
- Region: Global
- North America held over 40% of the global revenue for soil fumigants, with a market size of USD 1.01 billion (USD 1005.80 million) in 2024.
-
Agricultural Biologicals (including Biopesticides, Biostimulants, Biofertilizers, and Specialty Nutritionals): The global agricultural biologicals market was valued at USD 15.10 billion in 2024 and is projected to grow to USD 43.58 billion by 2032.
- Region: Global
- North America held a dominant share, valued at USD 4.81 billion in 2024.
-
Precision Agriculture Technologies: The global precision agriculture market size is projected to reach USD 21.47 billion by 2033.
- Region: Global
AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for American Vanguard (AVD) over the next 2-3 years:- Growth in Green Solutions and Biological Products: American Vanguard is strategically positioned in the expanding biopesticides market, which is projected to grow from USD $6.72 billion in 2025 to USD $11.41 billion by 2030, at an 11.19% compound annual growth rate. The company boasts over 120 biological solutions globally, including biopesticides, biostimulants, and biofertilizers, with this portfolio showing an 18% year-over-year growth in Q3 2024 and anticipated double-digit growth in 2025.
- Advancement in Precision Agriculture Technologies: The company is making significant investments in precision agriculture, notably with its SIMPAS prescriptive application system and Ultimus measure/record/verify technologies. This focus on applying crop protection and bio-nutritional inputs precisely where and when needed is a key strategic growth area.
- International Market Expansion and Enhanced Market Access: American Vanguard has a strategic emphasis on expanding its international presence, already operating in 19 to 21 countries with over 1,000 product registrations across 56 nations. The company anticipates a strengthening of sales in Central and South American markets in the latter half of 2025, further bolstered by acquisitions providing market rights in regions like Argentina and Chile.
- New Product Development and Strategic Acquisitions: American Vanguard's growth strategy includes both developing new products and acquiring established brands. The company maintains a robust pipeline of new herbicides, insecticides, nematicides, and fungicides, with introductions planned through the mid-2020s. Recent examples of this strategy include the 2021 introductions of Impact Core® and Sinate® Herbicides, and the acquisition of the Envoke® herbicide brand.
- Recovery in Core Agricultural Markets: AVD expects a recovery in its core agricultural business, which has recently faced cyclical downturns and customer inventory reductions. Analysts project a rebound in these cyclical margins and a return to more normalized sales levels, with increased corn plantings specifically highlighted as a positive indicator for the company’s soil insecticide offerings.
AI Analysis | Feedback
Capital Allocation Decisions of American Vanguard (AVD) (Last 3-5 Years)
Share Repurchases
- American Vanguard authorized a program in May 2023 to repurchase up to $15 million of its common stock over the subsequent twelve months, beginning in June 2023.
- In August 2022, the company initiated an accelerated share repurchase (ASR) plan totaling $20 million, which was in addition to a 10b5-1 repurchase plan launched in March 2022.
- The company did not repurchase any common stock during the twelve months ended December 31, 2024, and is currently restricted from stock repurchases as of November 7, 2023, due to an Amended Loan and Security Agreement.
Share Issuance
- For the nine months ended September 30, 2024, American Vanguard received $901,000 from the issuance of ESPP shares and the exercise of stock options.
- For the nine months ended September 30, 2023, the company generated $980,000 through the issuance of ESPP shares and stock option exercises.
Outbound Investments
- On October 5, 2023, American Vanguard acquired all outstanding shares of Punto Verde, an agricultural product distributor based in Guayaquil, Ecuador.
- The company completed the purchase of certain assets related to the herbicide trifloxysulfuron ("Envoke") from Syngenta Crop Protection on July 1, 2021.
- In October 2020, American Vanguard's Australian subsidiary acquired AgNova, an Australian company specializing in specialty crop protection and production solutions, and AMVAC purchased all shares of Agrinos and associated intellectual property rights.
Capital Expenditures
- American Vanguard anticipates capital expenditures to be in the range of $8 million to $9 million for the full year 2025.
- Capital expenditures amounted to $7.28 million for fiscal year 2024 and $11.88 million for fiscal year 2023.
- The company's strategic growth initiatives, including precision application technologies like SIMPAS and Ultimus, and Green Solutions portfolio products, drive capital allocation.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| American Vanguard Earnings Notes | 12/16/2025 | |
| Would You Still Hold American Vanguard Stock If It Fell Another 30%? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 49.36 |
| Mkt Cap | 11.9 |
| Rev LTM | 9,315 |
| Op Inc LTM | 1,560 |
| FCF LTM | 852 |
| FCF 3Y Avg | 967 |
| CFO LTM | 1,867 |
| CFO 3Y Avg | 1,919 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 2.0% |
| Rev Chg 3Y Avg | -11.7% |
| Rev Chg Q | 12.4% |
| QoQ Delta Rev Chg LTM | 2.1% |
| Op Mgn LTM | 12.7% |
| Op Mgn 3Y Avg | 13.4% |
| QoQ Delta Op Mgn LTM | 1.7% |
| CFO/Rev LTM | 12.4% |
| CFO/Rev 3Y Avg | 12.8% |
| FCF/Rev LTM | 3.5% |
| FCF/Rev 3Y Avg | 5.9% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 11.9 |
| P/S | 1.0 |
| P/EBIT | 8.7 |
| P/E | 9.1 |
| P/CFO | 6.9 |
| Total Yield | 5.9% |
| Dividend Yield | 2.7% |
| FCF Yield 3Y Avg | 5.5% |
| D/E | 0.5 |
| Net D/E | 0.5 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 12.5% |
| 3M Rtn | 15.2% |
| 6M Rtn | 2.6% |
| 12M Rtn | 5.2% |
| 3Y Rtn | -21.2% |
| 1M Excs Rtn | 11.7% |
| 3M Excs Rtn | 12.0% |
| 6M Excs Rtn | -6.9% |
| 12M Excs Rtn | -10.8% |
| 3Y Excs Rtn | -89.3% |
Segment Financials
Revenue by Segment| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Developing, manufacturing and distributing chemical, biological and biorational products for | 579 | ||||
| Single Segment | 610 | 558 | 459 | 468 | |
| Total | 579 | 610 | 558 | 459 | 468 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Developing, manufacturing and distributing chemical, biological and biorational products for | 8 | ||||
| Total | 8 |
Price Behavior
Price Behavior
| Market Price | $5.12 | |
| Market Cap ($ Bil) | 0.1 | |
| First Trading Date | 06/22/1988 | |
| Distance from 52W High | -18.3% | |
| 50 Days | 200 Days | |
| DMA Price | $4.29 | $4.57 |
| DMA Trend | indeterminate | down |
| Distance from DMA | 19.2% | 12.1% |
| 3M | 1YR | |
| Volatility | 50.3% | 59.2% |
| Downside Capture | 114.04 | 71.36 |
| Upside Capture | 147.30 | 42.50 |
| Correlation (SPY) | 20.0% | 26.9% |
AVD Betas & Captures as of 1/31/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.26 | 1.18 | 0.91 | 1.01 | 0.82 | 0.80 |
| Up Beta | 6.23 | 6.07 | 1.10 | 2.35 | 0.97 | 1.08 |
| Down Beta | -2.09 | -0.74 | -0.26 | 0.52 | 0.92 | 0.74 |
| Up Capture | 387% | 192% | 188% | 94% | 32% | 6% |
| Bmk +ve Days | 11 | 22 | 34 | 71 | 142 | 430 |
| Stock +ve Days | 13 | 21 | 31 | 68 | 124 | 364 |
| Down Capture | -290% | 91% | 109% | 67% | 80% | 99% |
| Bmk -ve Days | 9 | 19 | 27 | 54 | 109 | 321 |
| Stock -ve Days | 5 | 16 | 26 | 51 | 114 | 358 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with AVD | |
|---|---|---|---|---|
| AVD | -16.4% | 59.2% | -0.08 | - |
| Sector ETF (XLB) | 15.9% | 20.3% | 0.62 | 40.2% |
| Equity (SPY) | 15.6% | 19.2% | 0.63 | 26.8% |
| Gold (GLD) | 77.2% | 24.5% | 2.30 | 7.2% |
| Commodities (DBC) | 10.0% | 16.5% | 0.40 | 5.4% |
| Real Estate (VNQ) | 2.9% | 16.5% | -0.00 | 31.3% |
| Bitcoin (BTCUSD) | -23.4% | 40.3% | -0.56 | 11.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with AVD | |
|---|---|---|---|---|
| AVD | -20.9% | 50.3% | -0.27 | - |
| Sector ETF (XLB) | 9.5% | 18.9% | 0.40 | 36.0% |
| Equity (SPY) | 14.5% | 17.0% | 0.68 | 25.9% |
| Gold (GLD) | 21.5% | 16.8% | 1.04 | 8.5% |
| Commodities (DBC) | 12.0% | 18.9% | 0.51 | 11.2% |
| Real Estate (VNQ) | 4.8% | 18.8% | 0.16 | 26.1% |
| Bitcoin (BTCUSD) | 20.9% | 57.5% | 0.56 | 12.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with AVD | |
|---|---|---|---|---|
| AVD | -6.2% | 47.1% | 0.05 | - |
| Sector ETF (XLB) | 12.5% | 20.7% | 0.54 | 46.5% |
| Equity (SPY) | 15.6% | 17.9% | 0.75 | 38.7% |
| Gold (GLD) | 15.6% | 15.5% | 0.84 | 6.3% |
| Commodities (DBC) | 8.4% | 17.6% | 0.39 | 17.3% |
| Real Estate (VNQ) | 5.6% | 20.8% | 0.24 | 33.4% |
| Bitcoin (BTCUSD) | 69.9% | 66.5% | 1.09 | 10.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/12/2025 | 3.3% | -2.9% | -11.3% |
| 6/6/2025 | 1.6% | -7.0% | -13.8% |
| 3/14/2025 | -5.7% | 1.1% | -20.0% |
| 11/12/2024 | 9.2% | 7.8% | -10.5% |
| 8/9/2024 | 9.4% | 11.3% | 18.2% |
| 3/18/2024 | 4.7% | 8.0% | -3.4% |
| 11/9/2023 | -7.5% | -5.1% | 3.5% |
| 8/9/2023 | -16.4% | -12.8% | -24.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 10 | 9 | 6 |
| # Negative | 10 | 11 | 14 |
| Median Positive | 1.6% | 5.5% | 12.1% |
| Median Negative | -2.4% | -5.1% | -9.5% |
| Max Positive | 9.4% | 11.3% | 24.7% |
| Max Negative | -16.4% | -12.8% | -24.5% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2025 | 11/10/2025 | 10-Q |
| 06/30/2025 | 07/31/2025 | 10-Q |
| 03/31/2025 | 06/06/2025 | 10-Q |
| 12/31/2024 | 05/29/2025 | 10-K |
| 09/30/2024 | 11/12/2024 | 10-Q |
| 06/30/2024 | 08/09/2024 | 10-Q |
| 03/31/2024 | 05/09/2024 | 10-Q |
| 12/31/2023 | 03/28/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/09/2023 | 10-Q |
| 03/31/2023 | 05/10/2023 | 10-Q |
| 12/31/2022 | 03/16/2023 | 10-K |
| 09/30/2022 | 11/08/2022 | 10-Q |
| 06/30/2022 | 08/08/2022 | 10-Q |
| 03/31/2022 | 05/04/2022 | 10-Q |
| 12/31/2021 | 03/14/2022 | 10-K |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.